JP2006527762A5 - - Google Patents

Download PDF

Info

Publication number
JP2006527762A5
JP2006527762A5 JP2006516807A JP2006516807A JP2006527762A5 JP 2006527762 A5 JP2006527762 A5 JP 2006527762A5 JP 2006516807 A JP2006516807 A JP 2006516807A JP 2006516807 A JP2006516807 A JP 2006516807A JP 2006527762 A5 JP2006527762 A5 JP 2006527762A5
Authority
JP
Japan
Prior art keywords
subject
immune response
biologically active
conjugate
erythrosphingosylcarbamoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006516807A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006527762A (ja
JP4782675B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2004/000534 external-priority patent/WO2004110496A1/en
Publication of JP2006527762A publication Critical patent/JP2006527762A/ja
Publication of JP2006527762A5 publication Critical patent/JP2006527762A5/ja
Application granted granted Critical
Publication of JP4782675B2 publication Critical patent/JP4782675B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006516807A 2003-06-18 2004-06-17 ワクチン接種用スフィンゴイドポリアルキルアミン抱合体 Expired - Fee Related JP4782675B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US47918503P 2003-06-18 2003-06-18
US60/479,185 2003-06-18
US50563803P 2003-09-25 2003-09-25
US60/505,638 2003-09-25
US53755304P 2004-01-21 2004-01-21
US60/537,553 2004-01-21
US54550504P 2004-02-19 2004-02-19
US60/545,505 2004-02-19
PCT/IL2004/000534 WO2004110496A1 (en) 2003-06-18 2004-06-17 Sphingoid polyalkylamine conjugates for vaccination

Publications (3)

Publication Number Publication Date
JP2006527762A JP2006527762A (ja) 2006-12-07
JP2006527762A5 true JP2006527762A5 (https=) 2007-08-02
JP4782675B2 JP4782675B2 (ja) 2011-09-28

Family

ID=33556649

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2006516807A Expired - Fee Related JP4782675B2 (ja) 2003-06-18 2004-06-17 ワクチン接種用スフィンゴイドポリアルキルアミン抱合体
JP2006516806A Expired - Fee Related JP4695075B2 (ja) 2003-06-18 2004-06-17 トランスフェクションで使用するためのスフィンゴ脂質ポリアルキルアミン抱合体
JP2006516809A Pending JP2006527763A (ja) 2003-06-18 2004-06-17 スフィンゴ脂質のポリアルキルアミン抱合体

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2006516806A Expired - Fee Related JP4695075B2 (ja) 2003-06-18 2004-06-17 トランスフェクションで使用するためのスフィンゴ脂質ポリアルキルアミン抱合体
JP2006516809A Pending JP2006527763A (ja) 2003-06-18 2004-06-17 スフィンゴ脂質のポリアルキルアミン抱合体

Country Status (8)

Country Link
US (4) US8242089B2 (https=)
EP (3) EP1638919B1 (https=)
JP (3) JP4782675B2 (https=)
AU (3) AU2004246904B2 (https=)
BR (1) BRPI0411505A (https=)
CA (1) CA2528402A1 (https=)
MX (1) MXPA05013746A (https=)
WO (3) WO2004110980A1 (https=)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20010688A1 (it) 2001-11-21 2003-05-21 Univ Roma Composti immunoregolatori.
EP1519714B1 (en) 2002-06-28 2010-10-20 Protiva Biotherapeutics Inc. Method and apparatus for producing liposomes
AU2004233873B2 (en) 2003-04-25 2010-11-18 The Penn State Research Foundation Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
EP1638919B1 (en) * 2003-06-18 2012-09-26 Biolab Ltd. Sphingolipids polyalkylamines conjugates
US7906122B2 (en) 2003-06-18 2011-03-15 Yissum Research Development Company Of The Hebrew University Of Jersusalem Sphingoid polyalkylamine conjugates for Hepatitis B virus vaccination
CA2532228C (en) 2003-07-16 2017-02-14 Protiva Biotherapeutics, Inc. Lipid encapsulated interfering rna
JP4764426B2 (ja) 2004-06-07 2011-09-07 プロチバ バイオセラピューティクス インコーポレイティッド カチオン性脂質および使用方法
CA2569664C (en) 2004-06-07 2013-07-16 Protiva Biotherapeutics, Inc. Lipid encapsulated interfering rna
EP1773857A4 (en) 2004-07-02 2009-05-13 Protiva Biotherapeutics Inc THE IMMUNE SYSTEM STIMULATING SIRNA MOLECULES AND APPLICATIONS THEREOF
WO2006074546A1 (en) * 2005-01-13 2006-07-20 Protiva Biotherapeutics, Inc. Lipid encapsulated interfering rna
GB0513431D0 (en) * 2005-06-30 2005-08-10 Kherion Technology Ltd Prophylactic compositions and uses
WO2007048046A2 (en) 2005-10-20 2007-04-26 Protiva Biotherapeutics, Inc. Sirna silencing of filovirus gene expression
CN101346393B (zh) 2005-11-02 2015-07-22 普洛体维生物治疗公司 修饰的siRNA分子及其应用
NZ569138A (en) 2005-12-15 2012-06-29 Centre Nat Rech Scient Cationic oligonucleotides automated methods for preparing same and their uses
WO2007127272A2 (en) * 2006-04-24 2007-11-08 The Cbr Institute For Biomedical Research Method of producing immunoliposomes and compositions thereof
US7915399B2 (en) 2006-06-09 2011-03-29 Protiva Biotherapeutics, Inc. Modified siRNA molecules and uses thereof
WO2008115198A2 (en) 2006-06-30 2008-09-25 University Of Georgia Research Foundation, Inc. Anthrax carbohydrates,synthesis and uses thereof
US8420607B2 (en) * 2006-06-30 2013-04-16 University Of Georgia Research Foundation, Inc. Anthrax carbohydrates, synthesis and uses thereof
US8877206B2 (en) 2007-03-22 2014-11-04 Pds Biotechnology Corporation Stimulation of an immune response by cationic lipids
WO2008139467A2 (en) 2007-05-09 2008-11-20 Biolab Ltd. Lipid conjugated cyclic carbonate derivatives, their synthesis, and uses
FR2926818B1 (fr) * 2008-01-30 2012-04-06 Centre Nat Rech Scient siRNA CATIONIQUES, SYNTHESE ET UTILISATION POUR L'ARN INTERFERENCE
CA2721333C (en) 2008-04-15 2020-12-01 Protiva Biotherapeutics, Inc. Novel lipid formulations for nucleic acid delivery
EP2276495B1 (en) 2008-04-17 2018-11-21 PDS Biotechnology Corporation Stimulation of an immune response by enantiomers of cationic lipids
CA2740000C (en) 2008-10-09 2017-12-12 Tekmira Pharmaceuticals Corporation Improved amino lipids and methods for the delivery of nucleic acids
GB0910723D0 (en) 2009-06-22 2009-08-05 Sylentis Sau Novel drugs for inhibition of gene expression
WO2011000107A1 (en) 2009-07-01 2011-01-06 Protiva Biotherapeutics, Inc. Novel lipid formulations for delivery of therapeutic agents to solid tumors
US9018187B2 (en) 2009-07-01 2015-04-28 Protiva Biotherapeutics, Inc. Cationic lipids and methods for the delivery of therapeutic agents
US8569256B2 (en) 2009-07-01 2013-10-29 Protiva Biotherapeutics, Inc. Cationic lipids and methods for the delivery of therapeutic agents
CA2803282C (en) 2009-07-06 2018-05-01 David E. Anderson Methods for preparing vesicles and formulations produced therefrom
JP5854559B2 (ja) 2009-07-06 2016-02-09 ヴァリエーション バイオテクノロジーズ インコーポレイテッド 小胞を調製する方法及びこれから製造される製剤
US8716464B2 (en) 2009-07-20 2014-05-06 Thomas W. Geisbert Compositions and methods for silencing Ebola virus gene expression
WO2011105520A1 (ja) * 2010-02-26 2011-09-01 国立大学法人 長崎大学 抗原または薬物送達複合体
US9006417B2 (en) 2010-06-30 2015-04-14 Protiva Biotherapeutics, Inc. Non-liposomal systems for nucleic acid delivery
WO2012006368A2 (en) * 2010-07-06 2012-01-12 Variation Biotechnologies, Inc. Compositions and methods for treating influenza
WO2012006367A2 (en) 2010-07-06 2012-01-12 Variation Biotechnologies, Inc. Compositions and methods for treating influenza
US10736844B2 (en) 2011-01-13 2020-08-11 Variation Biotechnologies Inc. Compositions and methods for treating viral infections
AU2013208693B2 (en) 2012-01-12 2017-12-07 Variation Biotechnologies Inc. Compositions and methods for treating viral infections
EP2806894A4 (en) 2012-01-27 2015-11-04 Variation Biotechnologies Inc METHODS AND COMPOSITIONS FOR THERAPEUTIC AGENTS
CA2876656C (en) 2012-06-15 2023-09-26 Pds Biotechnology Corporation Cationic lipid vaccine compositions and methods of use
CN113144188A (zh) * 2012-09-21 2021-07-23 Pds生物科技公司 改进的疫苗组合物和使用方法
CN105452465B (zh) * 2013-07-31 2019-06-21 奇比艾企业有限公司 鞘脂-聚烷基胺-寡核苷酸化合物
EP3027223A1 (en) * 2013-07-31 2016-06-08 QBI Enterprises Ltd. Methods of use of sphingolipid polyalkylamine oligonucleotide compounds
US10426737B2 (en) * 2013-12-19 2019-10-01 Novartis Ag Lipids and lipid compositions for the delivery of active agents
JP6339884B2 (ja) 2014-07-17 2018-06-06 富士フイルム株式会社 イミダゾール化合物およびそれを含有するリポソーム
BR112017014090A2 (pt) * 2014-12-29 2018-03-06 Bonac Corporation composição, e, métodos para produção de uma composição e estabilização de uma molécula de ácido nucleico.
WO2016125163A1 (en) 2015-02-04 2016-08-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. LIPID ASSEMBLIES AND USES THEREOF AND SOME pH AND ELECTROSTATIC MODULATING LIPIDS TO BE USED IN SAID ASSEMBLIES
CA3005251A1 (en) 2015-11-13 2017-05-18 Pds Biotechnology Corporation Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy
WO2019113200A1 (en) 2017-12-05 2019-06-13 Pds Biotechnology Corporation Methods and compositions comprising cationic lipids for stimulating type 1 interferon genes
WO2022115645A1 (en) 2020-11-25 2022-06-02 Akagera Medicines, Inc. Lipid nanoparticles for delivery of nucleic acids, and related methods of use
CA3256897A1 (en) 2022-05-25 2023-11-30 Akagera Medicines, Inc. Lipid nanoparticles for the administration of nucleic acids and their methods of use
EP4683906A1 (en) * 2023-03-22 2026-01-28 Shanghai Circode Biomed Co., Ltd Lipid compounds, lipid nanoparticles, and pharmaceutical compositions

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897355A (en) 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
EP0300213A1 (en) 1987-06-22 1989-01-25 Hexal-Pharma Gentechnik GmbH & Co. KG Hepatitis a viral peptide particle immunogens
JPH01213858A (ja) 1988-02-23 1989-08-28 Akai Electric Co Ltd ディスク・プレーヤ
FR2645866B1 (fr) 1989-04-17 1991-07-05 Centre Nat Rech Scient Nouvelles lipopolyamines, leur preparation et leur emploi
KR910008396Y1 (ko) * 1989-12-09 1991-10-18 삼성전자 주식회사 공기 조화기의 환기, 배수 장치
US5334761A (en) 1992-08-28 1994-08-02 Life Technologies, Inc. Cationic lipids
US5674908A (en) 1993-12-20 1997-10-07 Life Technologies, Inc. Highly packed polycationic ammonium, sulfonium and phosphonium lipids
JPH09508900A (ja) * 1994-02-02 1997-09-09 ザ リポソーム カンパニー、インコーポレーテッド 薬理学的に活性な化合物及びリポソーム並びにそれらの使用方法
US6075012A (en) 1994-02-11 2000-06-13 Life Technologies, Inc. Reagents for intracellular delivery of macromolecules
US5659011A (en) 1994-09-23 1997-08-19 Waldmann; John J. Agents having high nitrogen content and high cationic charge based on dicyanimide dicyandiamide or guanidine and inorganic ammonium salts
US5840710A (en) 1994-12-09 1998-11-24 Genzyme Corporation Cationic amphiphiles containing ester or ether-linked lipophilic groups for intracellular delivery of therapeutic molecules
US6071890A (en) * 1994-12-09 2000-06-06 Genzyme Corporation Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
US5976567A (en) * 1995-06-07 1999-11-02 Inex Pharmaceuticals Corp. Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
DE19521412A1 (de) * 1995-06-14 1996-12-19 Boehringer Mannheim Gmbh Neue kationische und polykationische Amphiphile, diese enthaltende Reagenzien und deren Verwendung
DE69727384T2 (de) 1996-05-24 2004-11-04 IC-VEC Ltd. Polykatonische sterin-derivate zur transfektion
DE19631189A1 (de) 1996-08-02 1998-02-05 Max Delbrueck Centrum Neuartige kationische Amphiphile für den liposomalen Gentransfer
DE69735382T2 (de) 1996-11-04 2006-11-30 Qiagen Gmbh Kationische reagenzien zür transfektion
US6180114B1 (en) * 1996-11-21 2001-01-30 University Of Washington Therapeutic delivery using compounds self-assembled into high axial ratio microstructures
FR2763943B1 (fr) * 1997-05-28 1999-07-09 Rhone Poulenc Rorer Sa Composes, leur preparation et leur utilisation pour le transfert d'acides nucleiques dans les cellules
WO1999002190A1 (en) 1997-07-11 1999-01-21 Genzyme Corporation Organ-specific targeting of cationic amphiphile/retinoblastoma encoding dna complexes for gene therapy
CA2299429C (en) * 1997-08-13 2010-04-20 Biontex Laboratories Gmbh New lipopolyamines,their preparation and the use thereof
AU747597B2 (en) * 1998-07-20 2002-05-16 Inex Pharmaceuticals Corporation Liposomal encapsulated nucleic acid-complexes
AU1548101A (en) * 1999-11-24 2001-06-04 Sagami Chemical Research Center Sphingosine derivatives
JP2001213858A (ja) * 1999-11-24 2001-08-07 Sagami Chem Res Center スフィンゴシン誘導体
GB9930533D0 (en) 1999-12-23 2000-02-16 Mitsubishi Tokyo Pharm Inc Nucleic acid delivery
US20020012998A1 (en) * 2000-03-29 2002-01-31 Igor Gonda Cationic liposomes
US20020188023A1 (en) * 2000-12-12 2002-12-12 Michael Jorgensen Compound
US20060014695A1 (en) * 2002-02-01 2006-01-19 Hamidreza Ghandehari Hpma-polyamine conjugates and uses therefore
EP1638919B1 (en) * 2003-06-18 2012-09-26 Biolab Ltd. Sphingolipids polyalkylamines conjugates

Similar Documents

Publication Publication Date Title
JP2006527762A5 (https=)
RU2470016C2 (ru) Производное бипиразола
HRP20150277T1 (hr) Modulatori atp-vezujuä†ih kasetnih transportera
JP2012532874A5 (https=)
HRP20161577T1 (hr) Inhibitori replikacije virusa gripe
BRPI0411505A (pt) uso de um composto, método para modular a resposta imune de um indivìduo, composição farmacêutica, vacina, complexo, e, kit para a captura de uma molécula biologicamente ativa
JP2009511084A5 (https=)
IL209499A (en) Human monoclonal antibody against influenza a virus, pharmaceutical compositions comprising the same and use thereof as medicaments
HUE043952T2 (hu) Módosított influenzavírus vakcinahatékonyság monitorozására és javítására
DK1644037T3 (da) Funktionell infulenza-virus-lignende partikler (VLP'er)
RU2008119501A (ru) Функциональные вирусоподоюные частицы гриппа (vlps)
JP2009535352A5 (https=)
EP2307549A4 (en) INFLUENZA VIRUS LIKE PARTICLES (VLPS) WITH HEMAGGLUTININE
JP2008530245A5 (https=)
JP2002531415A5 (https=)
JP2010522208A5 (https=)
JP2007302683A5 (https=)
MX2009004223A (es) Protocolo de inmunizacion contra los 4 serotipos del dengue.
HRP20170433T1 (hr) Pripravci spoja za izmjenu lipidiranog imunološkog odgovora, formulacije, i postupci
JP2011504486A5 (https=)
FR20C1043I1 (fr) Vaccins avec adjuvants dotés d'antigènes non virioniques préparés à partir de virus de la grippe cultivés dans une culture cellulaire
JP2010506926A5 (https=)
JP2014532722A5 (https=)
JP2013510169A5 (https=)
JP2010500284A5 (https=)